Subacute cutaneous lupus erythematosus induced or exacerbated by proton pump inhibitors.
Dam
Claus
C
Bygum
Anette
A
D053799:2-Pyridinylmethylsulfinylbenzimidazoles / Q000009:adverse effects*; D001323:Autoantibodies / Q000097:blood; D004381:Duodenal Ulcer / Q000188:drug therapy; D004941:Esophagitis / Q000188:drug therapy; D005260:Female; D006801:Humans; D064747:Lansoprazole; D008178:Lupus Erythematosus, Cutaneous / Q000139:chemically induced* / Q000175:diagnosis; D008297:Male; D008875:Middle Aged; D009853:Omeprazole / Q000009:adverse effects; D000077402:Pantoprazole; D054328:Proton Pump Inhibitors / Q000009:adverse effects*; D012867:Skin / Q000473:pathology
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D001323:Autoantibodies; D054328:Proton Pump Inhibitors; D064747:Lansoprazole; D000077402:Pantoprazole; D009853:Omeprazole